Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03142438 · ClinicalTrials.gov registry record · NA

The Evaluation of a Mask for the Treatment of Obstructive Sleep Apnea

A NA study of Obstructive Sleep Apnea, sponsored by Fisher and Paykel Healthcare.

Completed
Registry status
NA
Development phase
57
Enrollment target
1
Study location

NCT03142438 is a NA study of Obstructive Sleep Apnea that has completed, run by Fisher and Paykel Healthcare. The registered enrollment target is 57 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03142438, a NA study of Obstructive Sleep Apnea, has completed, sponsored by Fisher and Paykel Healthcare.

COMPLETED
Registry status
NA
Development phase
57 participants
Enrollment target
1
Study location

Study Summary

This investigation is a prospective, non randomized, non blinded study. This investigation is designed to evaluate the performance, comfort and ease of use with the F\&P trial full face and nasal mask amongst Obstructive Sleep Apnea (OSA) patients. Up to 70 OSA patients will be recruited from the North Texas Lung and Sleep Clinic (NTLSC) database

Conditions Studied

Interventions

  • DEVICE F&P Seal Improvement Project

Study Locations (1)

Texas

  • North texas Lung and Sleep Clinic - Fort Worth

Trial Details

FieldValue
Enrollment Target 57 participants
Start Date 2017-05-30
Est. Completion 2017-06-23
Phase NA

Sponsor

Fisher and Paykel Healthcare

25 total trials

What the Registry Record Tells You About NCT03142438

The ClinicalTrials.gov registry entry for NCT03142438 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (74% lower). The listed sponsor is Fisher and Paykel Healthcare, which has 25 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which F&P Seal Improvement Project is the first listed.

NCT03142438 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT03142438 about?

NCT03142438 is a clinical study titled "The Evaluation of a Mask for the Treatment of Obstructive Sleep Apnea". This investigation is a prospective, non randomized, non blinded study. This investigation is designed to evaluate the performance, comfort and ease of use with the F\&P trial full face and nasal mask amongst Obstructive Sleep Apnea (OSA) patients. Up to 70 OSA patients will be recruited from the No...

What is the current status of trial NCT03142438?

This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2017-05-30. Estimated completion is 2017-06-23.

What conditions does trial NCT03142438 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea.

What interventions are being tested in trial NCT03142438?

The interventions under investigation include: F&P Seal Improvement Project (DEVICE).

Who is sponsoring clinical trial NCT03142438?

This trial is sponsored by Fisher and Paykel Healthcare, which has 25 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03142438 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.